This inhibitor has shown promise as an anti-MM drug, and one of its proposed mechanisms is that USP-7 paralysis results in an enhanced ubiquitination and fragmentation of human and/or murine double minute-2 protein (HDM2) with subsequent p53 activation, which is thought to mediate MM cell death (10). The gene discussed is MDM2; the disease is Miyoshi myopathy.